# Scalable Expanded Access With Analysis of Neurofilament and Other Biomarkers for Ibudilast in ALS

> **NCT06743776** · — · AVAILABLE · sponsor: **Mayo Clinic**

## Conditions studied

- ALS

## Interventions

- **DRUG:** MN-166

## Key facts

- **NCT ID:** NCT06743776
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2026-03-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06743776

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06743776, "Scalable Expanded Access With Analysis of Neurofilament and Other Biomarkers for Ibudilast in ALS". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06743776. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*